The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless ...
At the event, LiTime presented a lineup of high-performance lithium battery products , including the 48V 100Ah Golf Cart ...
Choose this for its reliable power, clean output, and trusted brand support.
If you’re looking for a car that’s practical, intelligent, and ready for tomorrow, the MG Comet EV is the smart solution for ...
The Group31 is built with Grade A+ Cells and an advanced Battery Management System (BMS) that protects against overcharge, over-discharge, overcurrent, short circuits, and temperature risks. These ...
A Bluetooth Troubleshooter is an automated tool in Windows computers that helps users fix Bluetooth-related problems. Some of you might have used this tool to fix Bluetooth issues. Windows 11 has ...
The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...
Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test
Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint in a phase 2 trial in patients with gastric cancer. The biopharma evaluated the Bristol Myers Squibb-partnered ...
The biopharmaceutical company posted revenue of $12.22 billion in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $11.83 billion. Bristol Myers expects full-year ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results